Trial · NCT07891546
Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners
NCT07891546, Not applicable, Completed, Massachusetts General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners. Trials, record NCT07891546. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891546
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners
- NCT number
- NCT07891546
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 14 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Nursing Home Resident, Skilled Nursing Facility, Depression, Feasibility Studies, Caregiver
- Interventions
- Interventions for Stressful Transitions in Later Life (InSTILL)
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean Total Score Treatment Credibility | After session 1 of intervention (one week after baseline) | 2-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 4) scores indicate greater credibility. |
| Primary | Mean Total Score Client Satisfaction Questionnaire | Post-intervention (week 6) | 3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction. |
| Primary | Percentage of Eligible Participants Enrolled | Post-intervention (week 6) | Percentage of eligible approached individuals that are enrolled into the study. |
| Primary | Percentage of Participants with Missing Data | 1-month follow-up (week 10) | Percentage of all participants with no measure fully missing at follow-up. |
| Primary | Attendance Rate | Post-intervention (week 6) | Percentage of participants completing 6/8 sessions of the intervention. |
| Primary | Number of Adverse Events | 1-month follow-up (week 10) | Number of adverse events related to participation in the study. |
| Secondary | Patient Health Questionnaire-9 | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 9-item self-report measure of depression symptoms. Higher scores (min=0, max=27) indicate greater depressive symptoms. |
| Secondary | Selection, Optimization, and Compensation (SOC) in Everyday Use | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self-report measure of the application of selection, optimization, and compensation strategies in daily life. Items are averaged for a composite score, with higher scores indicate greater SOC strategy use (Range = 1-6). |
| Secondary | PROMIS Short Form v1.0 - Self-Efficacy for Managing Emotions 4a | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self-report measure of ability to manage difficult emotions. Higher scores indicate greater use and effectiveness of emotional regulation skills; raw scores will be converted to T-scores (normed, M=50, SD=10). |
| Secondary | PROMIS Global Mental Health-4 | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self report of overall emotional wellbeing. Raw scores are converted to T-scores (normed, M=50, SD=10) |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891546
GET https://conductscience.org/api/trials/v1/NCT07891546/registered